β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.
Daniel FerreiraScott A PrzybelskiTimothy G LesnickAfina W LemstraElisabet LondosFrederic BlancZuzana NedelskaChristopher G SchwarzJonathan Graff-RadfordMatthew L SenjemJulie A FieldsDavid S KnopmanRodolfo SavicaTanis J FermanNeill R Graff-RadfordVal J LoweClifford R JackRonald C PetersenBrit MollenhauerSara Garcia-PtacekCarla AbdelnourJakub HortLaura BonanniKetil OppedalMilica G KrambergerBradley F BoeveDag AarslandErik WestmanKejal KantarciPublished in: Neurology (2020)
This study provides Class II evidence that in patients with probable DLB, β-amyloid is associated with lower cognitive performance and tau pathology is associated with lower frequency of clinical features of DLB.